DalsnaFinance › IPOs › Milestone Pharmaceuticals › IPO
Milestone Pharmaceuticals Inc. completed its initial public offering on NASDAQ on May 9, 2019, pricing at $15.00 a share.
| Ticker | MIST |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | May 9, 2019 |
| Offering price | $15.00 |
| Shares offered | 5,500,000 |
| Total raised | $83M |
Milestone Pharmaceuticals Inc. sold 5,500,000 shares at $15.00 each on NASDAQ. Multiplied out, that is $82.5 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $83 million total recorded for the deal.
Milestone Pharmaceuticals Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Milestone Pharmaceuticals Inc.. This page is general information, not investment advice.